Real-World Description of Non-ICANS Neurologic Events Among Patients with Relapsed or Refractory Multiple Myeloma Treated with Ciltacabtagene Autoleucel Using Two Large US Databases. - Sidana S; Nagar SP; Ghosh S; Fan L; Alegria V; De Braganca KC; Lengil T; Sharma M; Pai H; Perciavalle M; Maitland J; Emond B; et al. (Oncology and therapy, 2026)